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Background/introduction
High intensity focused ultrasound (HIFU) surgery often
requires hours of ablation in order to treat an entire
tumor. Both perfluorocarbon gaseous microbubbles and
vaporized liquid droplets are known enhancers of HIFU
thermal ablation. Microbubbles, however, often lead to
surface or skin lesions. Furthermore, they have a rela-
tively short half-life in vivo (minutes) rendering them
insufficiently stable for an entire HIFU surgery, which
can last several hours. Many droplet formulations
require very high pressures to activate. Our aim was to
design an agent that could shorten ablation procedures
without sacrificing safety. We designed and investigated
a perfluorocarbon nanodroplet composed of a 1:1 ratio
of dodecafluoropentane and decafluorobutane. These are
tuned to change phase and activate at only 2 MPa peak
negative pressure with common HIFU pulse lengths,
enabling focused and targeted activation. Additionally,
they are stable at body temperature.
Methods
Two lipid-shelled agents, microbubbles (2.1 +/-0.5
micron diameter) and nanodroplets (240 +/-65 nm dia-
meter), were manufactured in-house. Effective circula-
tion time of the nanodroplets was investigated in vivo.
HIFU-induced temperature rises were measured as a
function of the time after the injection of the agent
occurred and were compared to controls wherein no
agent was injected. HIFU (1 MHz, 4.06 MPa, CW, 15
seconds) was applied in vivo to rat livers 5, 15 or 95
minutes after agent injection, and any thermal enhance-
ment was detected simultaneously by MR thermometry.
Results and conclusions
HIFU applied to livers without any agent induced only a
22 +/-3ºC maximal temperature rise over body tempera-
ture. The maximum HIFU-induced temperature rise
with microbubbles (55 +/-7 ºC) was observed 5 minutes
after their injection, whereas nanodroplets consistently
enhanced the HIFU thermal ablation at every time
point, with a peak temperature change 95 minutes after
their injection of 51 +/-12ºC (see Fig. 1). More impor-
tantly, the location where this heating occurred was
vastly different between the two agents. Microbubbles
primarily heated the surface of the animal and resulted
in skin burns, whereas no skin burns were present in
any of the control HIFU animals or those that received
nanodroplet injections with HIFU. Nanodroplets
resulted in HIFU heating at the target location with only
minimal surface heating that was not significantly differ-
ent from the baseline heating observed with HIFU alone
(grey line in Fig. 1B, 1C, 1D). These results suggest that
the nanodroplets are sufficiently stable to enhance HIFU
ablation in vivo for at least 1.5 hours, avoid skin burns,
and are a better option over microbubbles. These nano-
droplets could potentially reduce focused ultrasound
surgical procedure times by as much as 5 fold by more
quickly ablating a larger region of tissue, without com-
promising safety.
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Figure 1 MR-guided thermometry of HIFU ablation (15 seconds at 15 Watts) of rat liver following the injection of nanodroplet or microbubble
contrast agents. A) the hermometry map was divided into three regions for analysis: B) the target (focus) of the HIFU beam, C) the surface of
the animal, and D) the full treated volume. The peak temperature change was calculated for each animal. The gray solid line indicated the mean
temperature changed observed when HIFU was applied without an injection of contrast agents, and the dotted lines indicate one standard
deviation, *indicates significance (p<0.05) compared to the baseline temperature rise (gray line), †indicates significance (p<0.05) between
microbubbles and nanodroplets. (n=3 or 4, except for the 5 minute nanodroplet time point where n=2, data is displayed as the mean +/- S.D.)
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